By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Ferring Pharmaceuticals, Inc. 

400 Rella Boulevard

Suffern  New York  10901  U.S.A.
Phone: 914-333-8900 Fax:



Company News
Ferring Pharmaceuticals, Inc. Supports 25th Annual National Infertility Awareness Week With Launch Of 2014 Heart To Heart Video Contest 4/21/2014 8:53:22 AM
Ferring Pharmaceuticals, Inc. Looks Nationwide To Garner Support For The Women Veterans and Other Health Care Improvements Act Of 2013 11/11/2013 11:24:56 AM
Ferring Pharmaceuticals, Inc. Helps to Drive Rallying Call for Passage of the Women Veterans and Other Health Care Improvement Act of 2013 10/15/2013 9:03:36 AM
Ferring Pharmaceuticals, Inc. Adopts Local Morristown Playground 5/15/2013 8:51:27 AM
Ferring Pharmaceuticals Data Suggest Lower Risk of Cardiovascular Events or Deaths in Prostate Cancer Patients Treated With Degarelix Compared to LHRH Agonists 3/18/2013 10:46:41 AM
Ferring Pharmaceuticals, Inc. Announces Launch of Heart to Heart Video Contest 3/5/2013 1:14:14 PM
Ferring Pharmaceuticals, Inc. Release: In Patients With Active, Left-Sided Ulcerative Colitis, Study Shows Once-Daily Dose of Mesalazine Granules Provided Similar Results to Twice-Daily Dose 2/14/2013 9:43:45 AM
Ferring Pharmaceuticals, Inc. Acquires Licensing Rights for Elobixibat from Albireo 7/3/2012 9:38:07 AM
Ferring Pharmaceuticals, Inc. Release: FIRMAGON® (degarelix) Demonstrates Non-inferiority to goserelin with bicalutamide in Reducing Prostate Volume in Prostate Cancer Patients while Providing Better Relief from Lower Urinary Tract Symptoms 2/28/2012 7:02:47 AM
OctoPlus Enters Into Drug Development and Manufacturing Contract With Ferring Pharmaceuticals A/S 2/2/2012 9:44:49 AM